Dr. Jagat R. Kanwar

Deakin University, Australia

Email: jagat.kanwar@deakin.edu.au

Qualifications

1993 Ph.D., Molecular Immunology & Biotechnology, Postgraduate Institute of edical Education & Research, Chandigarh, India

1988 M.Sc., Medical Biotechnology, Punjab Agricultural University, Ludhiana, India

1984 B.Sc., Medical Sciences, Himachal Pradesh University, Shimla, India

Publications(Selected)

1. Jagat R. Kanwar, Mahidhara Ganesh and Rupinder K Kanwar. (2011) Anti-angiogenic therapy using nanotechnological based delivery system, Drug Discovery Today, 2011 Mar;16(5-6):188-202. IF: - 6.63, Top 5% in the field, Journal class: -A
2. MohantyChandana, Das Manasi, Jagat R. Kanwar and Sanjeeb K. Sahoo. (2011) Receptor mediated tumor targeting : an emerging approach for cancer therapy, Current Drug Delivery, 1/01/2011, 8(1): 45-58, IF:- 4.9
3. Shu-Ming He, Songshu Li, Jagat R. Kanwar and Shu-Feng Zhou. (2011) Structural and functional properties of human multidrug resistance protein 1 (MRP1/ABCC1), Current Medicinal Chemistry, in press 2011, 18, IF: - 4.9, Journal class: -B
4. E. Giuliano, B. W. Yarnall, R. Gupta, B. Dylan, J. R. Kanwar. (2011) Mitomycin C: A promising agent for the treatment of canine corneal scarring, Veterinary Ophthalmology, In Press. IF: - 1.516. Journal class:- B
5. H. Burrow, R. K. Kanwar, J. R. Kanwar (2011) Design antioxidant enzyme activities of iron saturated bovine lactoferrin (Fe-blf) in human gut epithelial HT29 cells under oxidative stress, Medicinal Chemistry, In Press. IF: - 2.82. Journal class: -B
6. J. R. Kanwar, Neha Singh, and R. K. Kanwar. (2011) Role of nanomedicine in reversing drug resistance mediated by ATP binding cassette transporters and p-glycoprotein in melanoma. Nanomedicine London UK. 2011 6(4): 701-714. IF:- 5.982, Top 5% in the field
7. Jagat R. Kanwar, Rajiv R. Mohan, Kanwar, K. Rupinder, Kislay Roy and Raj Bawa. (2010) Applications of aptamers in nanodelivery systems in cancer, eye and inflammatory diseases, Nanomedicine, 2010, 5(9): 1435-1445, IF:- 5.982, Top 5% in the field
8. Liam Matthews, Rupinder K. Kanwar, Shufeng Zhou, VasuPunj and Jagat R. Kanwar. (2010) Applications of nanomedicine in antibacterial medical therapeutics and diagnostics. Open Tropical Medicine Journal, 2010, 3(1)
9. Gibbons, Rupinder K. Kanwar and Jagat R. Kanwar. (2010) Effect of Bovine Lactoferrin on different Cancer Models. Frontiers in Bioscience, In Press. IF: - 3.063
10. Jagat R. Kanwar, Ganesh Mahidhara and Rupinder K. Kanwar. (2010) MicroRNA in human cancer and chronic inflammatory diseases, Frontiers in Bioscience (scholar edition), 1/06/2010, 9: 1113-1126, IF:- 3.063
11. Lixin Ma, HaiquanQiao, Changjun He, Qian Yang, Hei Antonio Chun Cheung, Jagat R. Kanwar and Xueying Sun. (2010) Modulating the interaction of CXCR4 and CXCL12 by low-molecular-weight heparin inhibits hepatic metastasis of colon cancer. Investigational New Drugs, online first 2010-11-15, IF:- 3.396
12. RangamRajkhowa, Lijing Wang, Jagat R. Kanwar and Xungai Wang. (2010) Molecular weight and secondary structure change in eri silk during alkali degumming and powdering, Journal of Applied Polymer Science, 2010, 119(3): 1339-1347, IF:- 1.187, Journal class: -B
13. Sara Baratchi, Rupinder K. Kanwar, Chun Hei Antonio Cheung and Jagat R. Kanwar. (2010) Proliferative and protective effects of SurR9-C84A on differentiated neural cells. Journal of Neuroimmunology, 8/10/2010, 227(1): 120-132, IF:- 2.841. Journal class:- B.Page 11 of 26
14. R. K. Kanwar, C. H. Cheung, J. Y. Chang and J. R. Kanwar. (2010) Recent advances in anti-survivin treatments for cancer. Current Medicinal Chemistry, 1/05/2010, 17(15): 1509-1515, IF:- 4.9. Journal class: -B
15. Alicia Wynne, Rupinder K. Kanwar, Rajiv Khanna and Jagat R. Kanwar. (2010) Recent advances on the possible neuroprotective activities of Epstein-Barr virus oncogene BARF1 protein in chronic inflammatory disorders of central nervous system. Current Neuropharmacology, 2010-09, 8(3): 268-275, IF:- 1.731. Journal class: -B